3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
6
Urinary Bladder Neoplasms
4
Colorectal Neoplasms
4
Adenocarcinoma Of Esophagus
3
Squamous Cell Carcinoma of Head and Neck
2
Rectal Neoplasms
2
Colonic Neoplasms
2
Cholangiocarcinoma
2
Anus Neoplasms
2
Tongue Neoplasms
1
Stomach Neoplasms
1
Salivary Gland Neoplasms
1
PRETEXT I Hepatoblastoma
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Lymphoid Interstitial Pneumonia
1
Laryngeal Neoplasms
1
Klatskin Tumor
1
Hypopharyngeal Neoplasms
1
HIV Infections
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Epstein-Barr Virus Infections
1
Endometrial Neoplasms
1
DNA Repair-Deficiency Disorders
1
Interventions
asciminib
3
ponatinib
2
nilotinib
2
fludarabine phosphate
2
Whole-Body Irradiation
2
Specimen Handling
2
Melphalan
2
Cyclophosphamide
2
Busulfan
2
ruxolitinib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
letermovir
1
Tyrosine Kinase Inhibitors
1
Tacrolimus
1
Stem Cell Transplantation
1
Sirolimus
1
Rituximab
1
Pharmaceutical Preparations
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Methotrexate
1
Imatinib Mesylate
1
Etoposide
1
Dasatinib
1
Cyclosporine
1
Cord Blood Stem Cell Transplantation
1
Clofarabine
1
CT-P10
1
Bone Marrow Purging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Chronic-Phase
×
dehydroftorafur
×
90 days
×
Clear all
No trials found.